Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK7-IN-13 is a pyrimidine-derived compound that is a potent inhibitor of CDK7. CDK7-IN-13 has the potential to be investigated in a variety of cancers (particularly those with dysregulated transcription).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 2,140.00 | |
50 mg | 6-8 weeks | $ 2,785.00 | |
100 mg | 6-8 weeks | $ 3,520.00 |
Description | CDK7-IN-13 is a pyrimidine-derived compound that is a potent inhibitor of CDK7. CDK7-IN-13 has the potential to be investigated in a variety of cancers (particularly those with dysregulated transcription). |
Molecular Weight | 452.5 |
Formula | C20H23F3N6OS |
CAS No. | 2765676-20-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK7-IN-13 2765676-20-6 inhibitor inhibit